Skip to main content
. Author manuscript; available in PMC: 2021 Sep 22.
Published in final edited form as: Pharmacoepidemiol Drug Saf. 2020 May 3;29(6):623–634. doi: 10.1002/pds.5014

Table 1.

Characteristics of patients ≥50 years old and free of dementia with an HbA1c between 6.5 and < 9.5 from the Veterans Health Administration (VHA; FY2002 to FY2012) and Kaiser Permanente Washington (KPW; 1996–2012) health care systemsa

Covariates, mean(±sd) or n(%)b VHA (n=112,845) KPW (n=14,333)
Index year
1996–1998 - 3653 (25.5)
1999–2000 - 1629 (11.4)
2001–2002 - 1457 (10.2)
2002–2004 13479 (11.9) -
2003–2004 - 1539 (10.7)
2005–2006 36461 (32.3) 1941 (13.5)
2007–2008 26859 (23.8) 1639 (11.4)
2009–2012 - 2475 (17.3)
2009–2010 22676 (20.1) -
2011–2012 13370 (11.9) -
Sociodemographic-related
Age (y) 62.6 (±9.0) 63.7 (±9.8)
Age category
 50–64 y 65532 (58.1) 8232 (57.4)
 65–74 y 33167 (29.4) 3711 (25.9)
 ≥ 75 y 14146 (12.5) 2390 (16.7)
Male gender 109220 (96.8) 6971 (48.6)
Race
 White 92425 (81.9) 10542 (73.6)
 Black 18206 (16.1) 695 (4.9)
 Asian -- 1183 (8.3)
 Other 2214 (2.0) 415 (2.9)
 Unknown -- 1498 (10.5)
Race (excluding unknown)
 White -- 10542 (82.1)
 Black -- 695 (5.4)
 Asian -- 1183 (9.2)
 Other -- 415 (3.2)
Missing race data 0 (0) 1498 (10.5)
Married 68404 (60.6) -
Low nSESc 56422 (50.0) 7065 (49.3)
VHA only insurance 47440 (42.0) -
Medicaid/Medicare - 6060 (42.3)
High healthcare utilization 28211 (25.0) 3559 (24.8)
Diabetes-related
HbA1c value 6.9 (±0.5) 7.1 (±0.7)
HbA1c category
 6.5 to < 7.0 80255 (71.1) 8028 (56.0)
 7.0 to < 7.5 19204 (17.0) 2996 (20.9)
 7.5 to < 8.0 7048 (6.3) 1488 (10.4)
 8.0 to < 8.5 3237 (2.9) 881 (6.2)
 8.5 to < 9.0 1920 (1.7) 569 (4.0)
 9.0 to < 9.5 1181 (1.1) 371 (2.6)
Creatinine value 1.0 (±0.2) 0.9 (±0.2)
Other comorbidities
Obesity 60277 (53.4) 6370 (44.4)
Hypertension 101308 (89.8) 7708 (53.8)
Hyperlipidemia 96157 (85.2) 4563 (31.8)
Stroke 7319 (6.5) 244 (1.7)
Ischemic heart disease 54731 (48.5) 2283 (15.9)
Congestive heart failure 19594 (17.4) 859 (6.0)
Atrial fibrillation 16219 (14.4) 939 (6.6)
Traumatic brain injury 6074 (5.4) 163 (1.1)
Vitamin B12 deficiency 5390 (4.8) 119 (0.8)
Psychiatric and substance comorbidities
Depression 26943 (23.9) 543 (3.8)
PTSD 17198 (15.2) 41 (0.3)
Other anxietyd 13253 (11.7) 337 (2.4)
Bipolar disorder 7187 (6.4) 168 (1.2)
Schizophrenia 5662 (5.0) 31 (0.2)
Nicotine abuse/dependence 56414 (50.0) 2182 (15.2)
Alcohol abuse/dependence 15627 (13.9) 241 (1.7)
Illicit drug abuse/dependence 7889 (7.0) 66 (0.5)
Other medications e
Statins 77221 (68.4) 3699 (25.8)
Anticholinergic drugs 45758 (40.6) 3170 (22.1)
NSAIDs 57696 (51.1) 2729 (19.0)
Antihypertensive drugs 98087 (86.9) 8875 (61.9)
a

FY = fiscal year; HbA1c = hemoglobin A1c; nSES = neighborhood socioeconomic status; NSAID = nonsteroidal anti-inflammatory drug; PTSD = posttraumatic stress disorder.

b

VHA measures covariates from start of FY00 to index HbA1c while KPW measures from 2 years prior and up to index HbA1c.

c

Low nSES = top 50th percentile of factor score from 7 measures obtained from 2009–2013 5-year census estimates from the American Community Survey.

d

Other anxiety disorders = panic disorder, obsessive-compulsive disorder, social phobia, generalized anxiety disorder, anxiety NOS.

e

Other medications associated with dementia = sustained use on or before index HbA1c (≥2 fills in a 6-mo period).